Skip to main content
. 2017 Mar 16;7:44782. doi: 10.1038/srep44782

Table 2. Effects of chitosan oligosaccharide supplementation on the amniotic fluid immune responses of sowsa.

Items Treatmentsb
P-value
CON COS
IL-1c (pg/mL) 163.33 ± 20.82 190.06 ± 49.46 0.250
IL-6d (pg/mL) 34.19 ± 6.46 30.79 ± 5.36 0.345
IL-10e (pg/mL) 109.67 ± 10.33 136.42 ± 15.36** 0.005
TNF-αf (pg/mL) 142.36 ± 22.36 155.72 ± 15.78 0.259
IgGg (μg/mL) 92.75 ± 21.92 152.17 ± 8.82** <0.001
IgAh (μg/mL) 64.23 ± 9.03 70.83 ± 10.40 0.268
IgMi (μg/mL) 76.26 ± 19.60 98.94 ± 12.98* 0.040

*P < 0.05 versus the CON group. **P < 0.01 versus the CON group.

aValues are means of six replications per treatment.

bCON: A corn-soybean basal diet; COS: Chitosan oligosaccharide (the basal diet supplemented with 100 mg/kg chitosan oligosaccharide).

cIL-1: Interleukin 1.

dIL-6, Interleukin 6.

eIL-10: Interleukin 10.

fTNF-α: Tumour necrosis factor α.

gIgG: Immunoglobulin G.

gIgA: Immunoglobulin A.

iIgM: Immunoglobulin M.